ENDOCRINOLOGY

Treatment of Infection in the Diabetic Foot: The Use of Antibiotics

Apr 14, 2017 by in ENDOCRINOLOGY Comments Off on Treatment of Infection in the Diabetic Foot: The Use of Antibiotics

Infection severity Probable pathogen(s) Antibiotic agent Comments Mild (usually treated with oral agent[s]) Staphylococcus aureus (MSSA); Streptococcus spp. Dicloxacillin Requires QID dosing; narrow-spectrum; inexpensive   Clindamycinb Usually active against community-associated MRSA,…

read more

Managing Diabetes in People with Foot Complications

Apr 14, 2017 by in ENDOCRINOLOGY Comments Off on Managing Diabetes in People with Foot Complications

Oral agent classes (e.g., denotes other agents in same class available) Biguanides (metformin) Sulphonylureas (e.g., gliclazide) Thiazolidinediones (pioglitazone) Alpha glucosidase inhibitors (acarbose) Meglitinides (e.g., repaglinide) Dipeptidyl peptidase-4 (DPP-4) inhibitors (e.g.,…

read more

Cholesterol Absorption Inhibitors (Ezetimibe) and Bile Acid Binding Resins (Colesevelam HCl) as Therapy for Dyslipidemia in Patients with Diabetes Mellitus

Apr 14, 2017 by in ENDOCRINOLOGY Comments Off on Cholesterol Absorption Inhibitors (Ezetimibe) and Bile Acid Binding Resins (Colesevelam HCl) as Therapy for Dyslipidemia in Patients with Diabetes Mellitus

Fig. 22.1 Title: Adiposopathy: Simplified relationship between pathogenic adipose tissue and cardiovascular disease [2]. Adiposopathy is promoted by unhealthy nutrition and a sedentary lifestyle in genetically and environmentally predisposed individuals….

read more

The PPAR System in Diabetes

Apr 14, 2017 by in ENDOCRINOLOGY Comments Off on The PPAR System in Diabetes

(1) ClinSciences, 10 avenue Victor Hugo, 21000 Dijon, France     Jean Claude Ansquer Email: jean-claude.ansquer@clinsciences.fr Abstract Peroxisome proliferator-activated receptors (PPARs), with three existing isoforms (PPAR α, PPAR β/δ, and PPAR γ), belong…

read more
Get Clinical Tree app for offline access